• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAC1 抑制可改善 IBSP 诱导的肺腺癌骨转移。

RAC1 inhibition ameliorates IBSP-induced bone metastasis in lung adenocarcinoma.

机构信息

School of Medicine, Tongji University, Shanghai 200433, China; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.

Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, Shanghai 200433, China.

出版信息

Cell Rep. 2024 Aug 27;43(8):114528. doi: 10.1016/j.celrep.2024.114528. Epub 2024 Jul 24.

DOI:10.1016/j.celrep.2024.114528
PMID:39052477
Abstract

Macrophage-to-osteoclast differentiation (osteoclastogenesis) plays an essential role in tumor osteolytic bone metastasis (BM), while its specific mechanisms remain largely uncertain in lung adenocarcinoma BM. In this study, we demonstrate that integrin-binding sialoprotein (IBSP), which is highly expressed in the cancer cells from bone metastatic and primary lesions of patients with lung adenocarcinoma, can facilitate BM and directly promote macrophage-to-osteoclast differentiation independent of RANKL/M-CSF. In vivo results further suggest that osteolytic BM in lung cancer specifically relies on IBSP-induced macrophage-to-osteoclast differentiation. Mechanistically, IBSP regulates the Rac family small GTPase 1 (Rac1)-NFAT signaling pathway and mediates the forward shift of macrophage-to-osteoclast differentiation, thereby leading to early osteolysis. Moreover, inhibition of Rac1 by EHT-1864 or azathioprine in mice models can remarkably alleviate IBSP-induced BM of lung cancer. Overall, our study suggests that tumor-secreted IBSP promotes BM by inducing macrophage-to-osteoclast differentiation, with potential as an early diagnostic maker for BM, and Rac1 can be the therapeutic target for IBSP-promoted BM in lung cancer.

摘要

巨噬细胞向破骨细胞分化(破骨细胞生成)在肿瘤溶骨性骨转移(BM)中起着至关重要的作用,而其在肺腺癌 BM 中的具体机制在很大程度上仍不清楚。在这项研究中,我们证明了整合素结合唾液蛋白(IBSP)在肺腺癌患者骨转移和原发性病变的癌细胞中高度表达,它可以促进 BM,并直接促进巨噬细胞向破骨细胞分化,而不依赖于 RANKL/M-CSF。体内结果进一步表明,肺癌的溶骨性 BM 特别依赖于 IBSP 诱导的巨噬细胞向破骨细胞分化。在机制上,IBSP 调节 Rac 家族小 GTP 酶 1(Rac1)-NFAT 信号通路,并介导巨噬细胞向破骨细胞分化的前向转移,从而导致早期溶骨。此外,在小鼠模型中,用 EHT-1864 或硫唑嘌呤抑制 Rac1 可以显著缓解 IBSP 诱导的肺癌 BM。总的来说,我们的研究表明,肿瘤分泌的 IBSP 通过诱导巨噬细胞向破骨细胞分化来促进 BM,具有作为 BM 的早期诊断标志物的潜力,而 Rac1 可以作为 IBSP 促进肺腺癌 BM 的治疗靶点。

相似文献

1
RAC1 inhibition ameliorates IBSP-induced bone metastasis in lung adenocarcinoma.RAC1 抑制可改善 IBSP 诱导的肺腺癌骨转移。
Cell Rep. 2024 Aug 27;43(8):114528. doi: 10.1016/j.celrep.2024.114528. Epub 2024 Jul 24.
2
Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.遗传和药理学激活 Hedgehog 信号通路抑制破骨细胞生成,并通过抑制 JNK/c-Fos-NFATc1 级联反应部分减轻钛颗粒诱导的骨溶解。
Theranostics. 2020 May 17;10(15):6638-6660. doi: 10.7150/thno.44793. eCollection 2020.
3
ITGB3-enriched extracellular vesicles mediate the formation of osteoclastic pre-metastatic niche to promote lung adenocarcinoma bone metastasis.富含 ITGB3 的细胞外囊泡介导破骨细胞前转移龛的形成,促进肺腺癌骨转移。
Mol Carcinog. 2024 Nov;63(11):2190-2204. doi: 10.1002/mc.23803. Epub 2024 Aug 13.
4
Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.肿瘤来源的外泌体 lncRNA-SOX2OT 通过靶向破骨细胞中的 miRNA-194-5p/RAC1 信号轴促进非小细胞肺癌骨转移。
Cell Death Dis. 2021 Jul 2;12(7):662. doi: 10.1038/s41419-021-03928-w.
5
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.骨唾液蛋白(BSP)和核因子κB受体活化因子配体(RANKL)协同诱导破骨细胞生成和骨吸收。
J Bone Miner Res. 2005 Sep;20(9):1669-79. doi: 10.1359/JBMR.050511. Epub 2005 May 16.
6
SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.SREBP-2 通过促进破骨细胞生成和乳腺癌转移加重乳腺癌相关性溶骨。
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):115-125. doi: 10.1016/j.bbadis.2018.10.026. Epub 2018 Oct 28.
7
Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.乳腺癌细胞诱导的 Hedgehog 信号通路促进破骨细胞生成和骨溶解。
J Biol Chem. 2011 Mar 18;286(11):9612-22. doi: 10.1074/jbc.M110.174920. Epub 2010 Dec 18.
8
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.一种c-fms酪氨酸激酶抑制剂Ki20227,在骨转移模型中可抑制破骨细胞分化和溶骨性骨破坏。
Mol Cancer Ther. 2006 Nov;5(11):2634-43. doi: 10.1158/1535-7163.MCT-05-0313.
9
Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.破骨细胞中骨唾液酸蛋白的靶向过表达促进乳腺癌细胞的骨转移。
J Cell Physiol. 2009 Jan;218(1):135-45. doi: 10.1002/jcp.21576.
10
Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis.确定Rac1和Rac2对破骨细胞生成的相对贡献。
J Bone Miner Res. 2008 Feb;23(2):260-70. doi: 10.1359/jbmr.071013.

引用本文的文献

1
Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets.肿瘤转移中的粘着斑:从分子机制到治疗靶点
Biomark Res. 2025 Mar 5;13(1):38. doi: 10.1186/s40364-025-00745-7.